NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Evopoint Biosciences

Evopoint Biosciences

Private
SuzhouHealthcare & Life Scienceshttps://evopointbio.com/

Last Round

Series E

Feb 20, 2024

Est. Valuation

$752.3M

Total Funding Raised

$242.2M

Company Overview

Evopoint Biosciences is a biopharmaceutical company that develops therapies for oncology, infectious diseases, and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCsprotein degradersprecision oncologymultidrug-resistant infectionsMDR infectionssmall molecule discoverylate-stage clinical trialspharma out-licensingR&D to BD modeltargeted protein degradationTPDundruggable targetsCLDN18.2 ADCNew Drug ApplicationNDAPARG inhibitorEZH2 inhibitor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evopoint Biosciences Comparables

Compare Evopoint Biosciences with similar companies based on industry and business-model similarity.

Evopoint Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Teligene
66%
Nodus Oncology
54%
Crystalys Therapeutics
54%

Evopoint Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EFeb 20, 2024
Series DDec 31, 2020
Series CAug 25, 2020
Series BJun 26, 2019
Series AMay 24, 2018
Angel
Nov 1, 2017

Evopoint Biosciences Investors

Notable investors and investment history

Evopoint Biosciences investors
InvestorRounds
Tencent ExplorationSeries E
Loyal Valley CapitalSeries E, Series A, Series C
Agricultural Bank of China InternationalSeries D
Jinan Industrial Development Investment GroupSeries E
Chenhai CapitalSeries E
Jiuyou CapitalSeries D, Series C
Oceanpine CapitalSeries C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 31, 2020

    Led by Oceanpine Capital with participation from Agricultural Bank of China International.

  • Nov 1, 2017

    Completed an Angel funding round.

Evopoint Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evopoint Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evopoint Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2017
Last FundingFeb 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.